Cardiotoxicity of 5-fluorouracil in a young colorectal cancer patient - Case report and review of literature

Archives of Medical Science

Volumn 5, Issue 2, 2009, Pages 277-280

  Wysocki, Piotr J ^a   Hutka, Małgorzata ^b  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

5 Fluorouracil; Cardiotoxicity; Pyrimidine analogues

Indexed keywords

AMLODIPINE; CAPECITABINE; DEXAMETHASONE; FLUOROURACIL; FOLINIC ACID; GLYCEROL NITRATE; ISOSORBIDE MONONITRATE; ONDANSETRON; OXALIPLATIN;

ABSENCE OF SIDE EFFECTS; ADJUVANT THERAPY; ADULT; ANAMNESIS; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CARDIOTOXICITY; CASE REPORT; CLINICAL FEATURE; COLORECTAL CANCER; CONTINUOUS INFUSION; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; LIVER METASTASIS; MULTIPLE CYCLE TREATMENT; ST SEGMENT DEPRESSION; THORAX PAIN;

EID: 70349658867     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Roth A, Kolaric K, Popovic S. Letter: Cardiotoxicity of 5-fluorouracil (NSC-19893). Cancer Chemother Rep 1975; 59: 1051-2.
2. Akhtar SS, Salim KP, Bano ZA. Symptomatic cardiotoxicity with high-dose 5-fluorouracil infusion: a prospective study. Oncology 1993; 50: 441-4.
3. de Forni M, Malet-Martino MC, Jaillais P, et al. Cardiotoxicity of high-dose continuous infusion fluorouracil: a prospective clinical study. J Clin Oncol 1992; 10: 1795-801.
4. Kosmas C, Kallistratos MS, Kopterides P, et al. Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study. J Cancer Res Clin Oncol 2008; 134: 75-82.
5. Talapatra K, Rajesh I, Rajesh B, Selvamani B, Subhashini J. Transient asymptomatic bradycardia in patients on infusional 5-fluorouracil. J Cancer Res Ther 2007; 3: 169-71.
6. Rezkalla S, Kloner RA, Ensley J, et al. Continuous ambulatory ECG monitoring during fluorouracil therapy: a prospective study. J Clin Oncol 1989; 7: 509-14.
7. Lestuzzi C, Viel E, Picano E, Meneguzzo N. Coronary vasospasm as a cause of effort-related myocardial ischemia during low-dose chronic continuous infusion of 5-fluorouracil. Am J Med 2001; 111: 316-8.
8. Matsubara I, Kamiya J, Imai S. Cardiotoxic effects of 5-fluorouracil in the guinea pig. Jpn J Pharmacol 1980; 30: 871-9.
9. Sudhoff T, Enderle MD, Pahlke M, et al. 5-Fluorouracil induces arterial vasocontractions. Ann Oncol 2004; 15: 661-4.
10. Stevenson DL, Mikhailidis DP, Gillett DS. Cardiotoxicity of 5-fluorouracil. Lancet 1977; 2: 406-7.
11. Lemaire L, Malet-Martino MC, Longo S, Martino R, de Forni M, Carton M. Fluoroacetaldehyde as cardiotoxic impurity in fluorouracil (Roche). Lancet 1991; 337: 560.
12. Arbea L, Coma-Canella I, Martinez-Monge R, Garcia-Foncillas J. A case of capecitabine-induced coronary microspasm in a patient with rectal cancer. World J Gastroenterol 2007; 13: 2135-7.
13. Mizuno Y, Hokamura Y, Kimura T, Kimura Y, Kaikita K, Yasue H. A case of 5-fluorouracil cardiotoxicity simulating acute myocardial infarction. Jpn Circ J 1995; 59: 303-7.
14. Cwikiel M, Zhang B, Eskilsson J, Wieslander JB, Albertsson M. The influence of 5-fluorouracil on the endothelium in small arteries. An electron microscopic study in rabbits. Scanning Microsc 1995; 9: 561-76.
15. Kinhult S, Albertsson M, Eskilsson J, Cwikiel M. Effects of probucol on endothelial damage by 5-fluorouracil. Acta Oncol 2003; 42: 304-8.
16. Sasson Z, Morgan CD, Wang B, Thomas G, MacKenzie B, Platts ME. 5-Fluorouracil related toxic myocarditis: case reports and pathological confirmation. Can J Cardiol 1994; 10: 861-4.
17. Tsibiribi P, Bui-Xuan C, Bui-Xuan B, et al. Cardiac lesions induced by 5-fluorouracil in the rabbit. Hum Exp Toxicol 2006; 25: 305-9.
18. Schöber C, Papageorgiou E, Harstrick A, et al. Cardiotoxicity of 5-fluorouracil in combination with folinic acid in patients with gastrointestinal cancer. Cancer 1993; 72: 2242-7.
19. Jensen SA, Sørensen JB. Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine. Cancer Chemother Pharmacol 2006; 58: 487-93.
20. Keefe DL, Roistacher N, Pierri MK. Clinical cardiotoxicity of 5-fluorouracil. J Clin Pharmacol 1993; 33: 1060-70.
21. Robben NC, Pippas AW, Moore JO. The syndrome of 5-fluorouracil cardiotoxicity. An elusive cardiopathy. Cancer 1993; 71: 493-509.
22. Eskilsson J, Albertsson M, Mercke C. Adverse cardiac effects during induction chemotherapy treatment with cis-platin and 5-fluorouracil. Radiother Oncol 1988; 13: 41-6.